Page last updated: 2024-08-23

nigericin and Leukemia, Lymphocytic, Chronic, B-Cell

nigericin has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carson, DA; Castro, JE; Choi, MY; Kipps, TJ; Lu, D; Yu, J1

Other Studies

1 other study(ies) available for nigericin and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Aug-09, Volume: 108, Issue:32

    Topics: Apoptosis; beta Catenin; Calcium; Down-Regulation; Gene Expression Regulation, Leukemic; Genes, Neoplasm; HEK293 Cells; Humans; LDL-Receptor Related Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Low Density Lipoprotein Receptor-Related Protein-6; Nigericin; Phosphorylation; Pyrans; Signal Transduction; Thapsigargin; Wnt Proteins

2011